HEAVY CHAIN ANTIBODIES BINDING TO PSMA

ANTI-PSMA ANTIBODIES, VARIANTS, AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING CANCER

PROTEIN-BASED CARRIERS FOR SITE-SPECIFIC AMINE CONJUGATION

Antibodies Against Human Siglec-7 and Use Thereof for Immunotherapy

Antibodies That Bind Human Cannabinoid 1 (CB1) Receptor

Antibodies Against Extracellular Epitopes of Human TRPV6 Channel and their Diagnostic and Therapeutic Uses

ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES AND METHOD OF USE THEREOF

DOSAGE AND ADMINISTRATION REGIMEN FOR THE TREATMENT OR PREVENTION OF GUILLAN-BARRÉ SYNDROME BY THE USE OF THE ANTI-C5 ANTIBODY CROVALIMAB

SEPARATION OF TRIPLE-LIGHT CHAIN ANTIBODIES USING CATION EXCHANGE CHROMATOGRAPHY

ANTI-TRANSFERRIN RECEPTOR ANTIBODIES, CONJUGATES THEREOF, AND USES THEREOF

HUMAN FC VARIANTS HAVING IMPROVED FCGRIIA BINDING SELECTIVITY

COMBINATION THERAPY OF BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD47 AND BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD3

ANTI-CD39 NANOBODY AND USES THEREOF

BIOSYNTHETIC BIOPARATOPIC OR BISPECIFIC BINDING MOLECULES WITH ENHANCED EFFECTOR FUNCTIONS

ANTIBODIES TARGETING IL-18 RECEPTOR BETA (IL-18RB) AND RELATED METHODS

ONCOSTATIN M RECEPTOR ANTIGEN BINDING PROTEINS

ANTI-EGFR ANTIBODIES, ANTI-CMET ANTIBODIES, ANTI-VEGF ANTIBODIES, MULTISPECIFIC ANTIBODIES, AND USES THEREOF

ANTI-DECTIN-1 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-MIC ANTIBODIES WITH VARIANT FC DOMAINS

A FUSION POLYPEPTIDE AND ITS USE

VARIANT ANTIBODIES THAT BIND GAMMA-DELTA T CELL RECEPTORS

CD3-BINDING PROTEINS AND METHODS OF USE THEREOF

TREATMENT OF MAST CELL RELATED DISORDERS

ANTI-GPRC5D ANTIBODIES AND COMPOSITIONS

CONNEXIN 43 ANTIBODIES AND USE THEREOF

Production of Biosimilar Ustekinumab In CHO Cells

Antibodies to Botulinum Neurotoxins

ANTIBODIES FOR TREATMENT OF CORONAVIRUS DISEASE

Fusion Molecules Of CTLA4 And IL-15

LONG-ACTING GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR

ANTI-PTK7 ANTIBODY AND USES THEREOF

ANTI-MUC1 ANTIBODY-DRUG CONJUGATE

ANTIBODY VARIANTS AND USES THEREOF

WNT SURROGATE MOLECULES AND USES THEREOF

MONOCLONAL ANTIBODIES AND BISPECIFIC ANTIBODY AGAINST C-MET

MULTISPECIFIC BINDING PROTEINS THAT BIND DECTIN-1 AND CD20 AND METHODS OF USE THEREOF

HUMAN ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF SPECIFIC AGAINST PD-L1 TO ENHANCE T-CELL FUNCTION

BISPECIFIC ANTI-CD28 X ANTI-CD22 ANTIBODIES AND USES THEREOF

NOVEL ANTI-CD3 ANTIBODIES AND USES THEREOF

ANTI-PVRIG ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF

Compounds

MONOCLONAL ANTIBODY AGAINST NERVE GROWTH FACTOR, AND ENCODING GENE AND USE THEREOF

FCRN/ANTIGEN-BINDING MOLECULES AND METHODS OF USE

PH-DEPENDENT HSA-BINDING MOLECULES AND METHODS OF USE

ANTI-SERUM ALBUMIN NANOBODY AND DERIVATIVE THEREOF

SARS-COV2 ANTIBODIES AND USES THEREOF

COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2 ANTIBODIES

MODIFIED ANTIGEN BINDINGPOLYPEPTIDE CONSTRUCTS AND USES THEREOF

HUMANIZED ANTI-NUCLEAR ANTIBODIES FOR TARGETING NECROSIS IN CANCER THERAPY

ACTIVATABLE MULTISPECIFIC MOLECULES AND METHODS OF USE THEREOF

ANTI-HER2/ANTI-CD47 MOLECULES AND USES THEREOF

ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS

MULTISPECIFIC NK ENGAGER PROTEIN

ANTI-CD39 ANTIBODY

NOVEL SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) BINDING MOLECULES AND USES THEREOF

BISPECIFIC ANTIBODIES AND METHODS OF USE

ANTIGEN BINDING PROTEIN TARGETING CD40, AND PREPARATION THEREFOR AND USE THEREOF

ANTIBODIES THAT SPECIFICALLY BIND TO API5 PROTEIN

ANTI-HUMAN INTERLEUKIN 36 RECEPTOR MONOCLONAL ANTIBODY AND USE THEREOF

DEVELOPMENT AND USE OF NOVEL IMMUNOMODULATOR

PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

METHOD OF USING AN ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) ACTIVATABLE ANTIBODY TO DETECT THE PRESENCE OR ABSENCE OF A CLEAVING AGENT AND EGFR

Human Epidermal Growth Factor Receptor Binding Molecule and Use Thereof

Anti-GAL3 Antibodies and Compositions

ANTIGEN-BINDING PROTEIN TARGETING PD-L1 AND CD40, PREPARATION THEREFOR, AND USE THEREOF

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING MAGE-A

ANTI-CD19 AGENT AND B CELL TARGETING AGENT COMBINATION THERAPY FOR TREATING B CELL MALIGNANCIES

TREM2 STABILIZING ANTIBODIES

ANTIBODIES SPECIFICALLY BINDING PD-1, TIM-3 OR PD-1 AND TIM-3 AND THEIR USES

MONOVALENT ANTI-TREM2 BINDING MOLECULES AND METHODS OF USE THEREOF

ISOFORM-SELECTIVE TGFB1 INHIBITORS AND USE THEREOF

ANTI-COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1 (CTHRC1) ANTIBODIES AND METHODS OF USING THE SAME

ANIMAL MODEL GENERATING HUMANIZED ANTIBODY AND CONSTRUCTION METHOD THEREOF

ANTI-KLK4 ANTIBODIES AND USES THEREOF

BINDING MOLECULES SPECIFIC TO HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2

ANTI-TROPHOBLAST CELL SURFACE ANTIGEN 2 (TROP-2) ANTIBODIES

DE-N-ACETYLATED POLYSIALIC ACID (dPSA) BINDING AGENT AND METHOD OF USING SAME

ANTI-CD36 ANTIBODIES AND USES THEREOF

ANTI-CD36 ANTIBODIES AND THEIR USE TO TREAT CANCER

CEACAM5-DEPENDENT 4-1BB-AGONISTIC BISPECIFIC ANTIBODIES

Anti-CD40 Antibodies for Use in Treatment of Sjogren's Syndrome

Anti-NGF Antibodies and Methods Thereof

Anti-NGF Antibodies and Methods Thereof

HIGH AFFINITY ANTIBODIES TO HUMAN IL-6 RECEPTOR

MULTI-SPECIFIC BINDING PROTEINS THAT BIND HER2, NKG2D, AND CD16, AND METHODS OF USE

Antibodies Binding to Vista at Acidic pH

DEIMMUNIZED ANTIBODIES SPECIFIC FOR CD3

METHODS OF CROSSLINKING IgG

RECOMBINANT ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AND USES THEREOF IN TREATING CANCERS

LIGANDS SPECIFIC FOR THE PCPE-1 GLYCOPROTEIN AND USES THEREOF

SINGLE DOMAIN ANTIBODIES AGAINST BEE VENOM EPITOPES

ANTI-ETEC ADHESIN PROTEIN ANTIBODIES AND METHODS OF USE

METHODS AND SYSTEMS FOR APPLICATIONS INVOLVING ANTIGEN-PRESENTING CELLS

BINDER MOLECULES WITH HIGH AFFINITY AND/ OR SPECIFICITY AND METHODS OF MAKING AND USE THEREOF

BINDING FUSION PROTEINS, BINDING FUSION PROTEIN-DRUG CONJUGATES, XTEN-DRUG CONJUGATES AND METHODS OF MAKING AND USING SAME

TRISPECIFIC BINDING PROTEINS AND METHODS OF USE

METHODS OF TREATMENT WITH ANTI-FACTOR XI/XIA ANTIBODIES

ANTI-CD20 ANTIBODIES AND THERAPEUTIC USES THEREOF

HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN IL-4 RECEPTOR

ANTIBODIES AND IgG FUSION PROTEINS WITH AN EXTENDED HALF-LIFE

METHODS FOR THE TREATMENT OF THYROID EYE DISEASE

METHODS FOR THE TREATMENT OF THYROID EYE DISEASE

Anti-FLT3 Antigen Binding Proteins

ANTI-LAG-3 ANTIBODIES TO TREAT HEMATOLOGICAL MALIGNANCIES

LAG-3 AGONIST ANTIBODIES

SIRP ALPHA, SIRP BETA 1, AND SIRP GAMMA ANTIBODIES AND USES THEREOF

COMPOSITIONS AND METHODS FOR MODULATION OF MACROPHAGE ACTIVITY

ANTI-CORTICOTROPIN-RELEASING HORMONE ANTIBODIES AND USE IN CONGENITAL ADRENAL HYPERPLASIA

IL-21 POLYPEPTIDES AND TARGETED CONSTRUCTS

METHODS FOR TREATING NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

ANTIBODIES TO NECROTIC ENTERITIS B-LIKE TOXIN

NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN LIVESTOCK ANIMALS AND METHODS OF USE

ACTIVATABLE IL-18 IMMUNOCYTOKINES AND USES THEREOF

COMPOSITIONS AND METHODS FOR SELECTIVE DEPLETION OF TARGET MOLECULES

ANTI-alpha-V-beta-8 INTEGRIN ANTIBODIES AND USES THEREOF

METHODS OF BLOOD SCREENING

CATABODIES AND METHODS OF USE THEREOF

PREPARATION METHOD AND APPLICATION OF NANOBODY TARGETING DENGUE VIRUS NS1 PROTEIN

ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF THAT TARGETS COTININE, CHIMERIC ANTIGEN RECEPTOR COMPRISING SAME, AND USES THEREOF

GLYCOFORM SPECIFIC NANOBODIES AND METHODS OF USE

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF

HUMAN ANTIBODIES AGAINST ACTIVATED PROTEIN C AND USES THEREOF

PH-SELECTIVE ANTIBODY FC DOMAINS

GLYCOSYLATED FC VARIANTS WITH IMPROVED SELECTIVE BINDING AFFINITY TO FCyRIIIA

COMPOSITIONS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND METHODS FOR MAKING AND USING THE SAME

ANTI-CD137 ANTIBODIES AND METHODS OF MAKING AND USING THE SAME

CD70 BINDING MOLECULES AND METHODS OF USE THEREOF

ANTI-IL-4RA ANTIBODIES AND USES THEREOF

BINDING PROTEINS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2b ANTIBODIES

ANTIBODIES AND VARIANTS THEREOF AGAINST HUMAN B7-H3

IL-18 POLYPEPTIDES FUSED TO IMMUNE CELL ANTIGEN SPECIFIC BINDING POLYPEPTIDES AND USES THEREOF

PHARMACEUTICAL COMPOSITION COMPRISING ANTI-CTLA4-ANTI-PD-1 BISPECIFIC ANTIBODY AND CHIAURANIB

GPRC5D ANTIBODIES WITH ENHANCED EFFECTOR FUNCTION AND USES THEREOF

TGF-ß ANTIBODIES

ANTIBODY COMPOSITIONS FOR DISRUPTING BIOFILMS

CORONAVIRUS ANTIBODIES AND USES THEREOF

HMPV ANTIBODIES AND THEIR USE

MAGNETIC RESONANCE IMAGE PROCESSING APPARATUS AND METHOD TO WHICH IMPROVEMENT IN SLICE RESOLUTION IS APPLIED

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

FUSION PROTEIN OF CD137 ANTIBODY AND CD40L AND USE THEREOF

SINGLE DOMAIN ANTIBODY LIBRARIES WITH MAXIMIZED ANTIBODY DEVELOPABILITY CHARACTERISTICS

PLASMIN-BINDING VHHS

PHARMACEUTICAL COMPOSITION COMPRISING ANTI-FXI/FXIA ANTIBODY AND USE THEREOF

Antibodies and antibody fragments and analogues specific for chondroitin sulfate

ANTI-CEACAM5 ANTIBODIES AND CONJUGATES AND USES THEREOF

NOVEL BISPECIFIC ANTIGEN BINDING MOLECULES CAPABLE OF SPECIFIC BINDING TO CD40 AND TO FAP

Antibodies That Specifically Bind to TL1A and Methods of Treating Skin Disease

METHODS AND COMPOSITIONS FOR INCREASING GALACTOSIDASE BETA-1 ACTIVITY IN THE CNS

GROWTH HORMONE RECEPTOR TARGETING POLYPEPTIDES

ANTIBODIES TO CANINE INTERLEUKIN-4 RECEPTOR ALPHA

HETEROMERIC AGONISTIC ANTIBODIES TO IL-18 RECEPTOR

MATERIALS AND METHODS OF MAKING OR USING IL-23R BINDING PROTEINS

ANTI-FLT3 ANTIBODIES AND COMPOSITIONS

FUSION PROTEIN COMPRISING MODIFIED ANTI-VEGFR2 (KDR) ANTIBODY AND USE THEREOF

BISPECIFIC DENDRITIC CELL ENGAGER AND USES THEREOF

Anti-SIRPa Antibodies and Methods of Use Thereof

ANTI PD-L2 ANTIBODY

ANTI-TREM1 ANTIBODIES AND RELATED METHODS

NK/MONOCYTE ENGAGERS

MULTI-SPECIFIC BINDING PROTEINS AND METHODS OF USE THEREOF

CD3-DELTA/EPSILON HETERODIMER SPECIFIC ANTIBODIES

CD5 ANTIBODY AND USE THEREOF

LAIR-1-BINDING AGENTS AND METHODS OF USE THEREOF

LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFb AND USES THEREOF

MODIFIED-IgG ANTIBODIES THAT BIND TRANSFORMING GROWTH FACTOR-BETA1 WITH HIGH AFFINITY, AVIDITY AND SPECIFICITY

Anti-Abeta Antibodies

MONOCLONAL ANTIBODIES, COMPOSITIONS AND METHODS FOR DETECTING COMPLEMENT FACTOR D

COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF IRON-RELATED DISORDERS

ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE

USE OF FCRN ANTAGONISTS FOR TREATMENT OF GENERALIZED MYASTHENIA GRAVIS

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

ROR1-TARGETED BINDING MOLECULE AND USE THEREOF

MOLECULES THAT BIND TO ENPP1 POLYPEPTIDES

TARGETED LIPOSOMAL GEMCITABINE AND METHODS THEREOF

METHODS AND COMPOSITIONS FOR CAR T CELL THERAPY

ANTI-CD38 ANTIBODIES

CHIMERIC ANTIGEN RECEPTOR CELLS FOR TREATING SOLID TUMOR

THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISORDER

MULTISPECIFIC ANTIBODIES FOR TREATING CD47-ASSOCIATED DISEASES

HUMANIZED COMPLEMENT 5A RECEPTOR 1 ANTIBODIES AND METHODS OF USE THEREOF

METHODS OF TREATING COMPLEMENT-MEDIATED DISEASE

Bispecific Constructs for Target and Complement Engagement

BCMA-TARGETING SINGLE-DOMAIN ANTIBODY

ANTI-CCR8 ANTIBODIES AND USES THEREOF

N-TERMINAL scFv MULTISPECIFIC BINDING MOLECULES

ANTI-PROGRAMMED DEATH-LIGAND 1 (PD-L1) ANTIBODIES

CANINE MONOCLONAL ANTIBODIES AGAINST CANINE CYTOTOXIC T LYMPHOCYTE ASSOCIATED PROTEIN 4 (CTLA-4)

METHOD OF TREATING DISEASE USING ANTI-CD47 X ANTI-MESOTHELIN ANTIBODIES AS A SOLE AGENT AND IN COMBINATION WITH ANTI-PD-1 ANTIBODIES

Methods of Bone Marrow Conditioning

ANTI-LILRB1/2 ANTIBODIES AND USES THEREOF

KIR3DL3 INHIBITORS AND IMMUNE CELL ACTIVATING AGENTS

ANTIBODY, NUCLEIC ACID, CELL, AND PHARMACEUTICAL

ANTIBODIES TARGETING IL3

COMPOSITIONS AND METHODS FOR INTERNALIZING ENZYMES

ANTI-EGFR ANTIBODY-DRUG CONJUGATES

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

HUMANIZED ANTI-TISSUE FACTOR ANTIBODY, ANTIBODY-DRUG CONJUGATE PREPARED THEREFROM AND USE THEREOF

ENVIRONMENTALLY-RESPONSIVE MASKED ANTIBODY AND USE THEREOF

MDR E. COLI IMMUNOGEN

EPITOPE ENGINEERING OF CELL-SURFACE RECEPTORS

IgE BINDING PROTEINS AND USES THEREOF

CAMELID ANTIBODIES AGAINST ACTIVATED PROTEIN C AND USES THEREOF

ENPP3 AND CD3 BINDING AGENTS AND METHODS OF USE THEREOF

ANTI-PROTHROMBIN ANTIBODIES TARGETING THE OPEN FORM OF PROTHROMBIN

ANTI-HER2/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF

MONOCLONAL ANTIBODY AGAINST TROP2 AND USE THEREOF

CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER

Combination Treatment for Cancer

NOVEL ANTIBODIES AND ANTIBODY CONJUGATES FOR THE TREATMENT OF METABOLIC DISORDERS

IL10 RECEPTOR BINDING MOLECULES AND METHODS OF USE

ANTIBODY COMPRISING IGG FC REGION VARIANT, AND USE THEREOF

ANTI-IL-13RA2 MONOCLONAL ANTIBODIES AND USES THEREOF

"TWO-IN-ONE"-ANTIBODIES BINDING TO EGFR/PD-L1-DOUBLE POSITIVE CELLS

Human Antigen Binding Proteins That Bind Beta-Klotho, FGF Receptors and Complexes Thereof

ANTI-EGFR ANTIBODIES AND ANTIBODY DRUG CONJUGATES

BISPECIFIC ANTIBODIES AGAINST CD277 AND A TUMOR-ANTIGEN

NOVEL MONOCLONAL ANTIBODIES TO CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4 (CTLA-4)

RELEASE SEGMENTS AND BINDING COMPOSITIONS COMPRISING SAME

ANTI-RAGE ANTIBODY

ANTI-FGF23 ANTIBODY OR ANTIBODY FRAGMENT THEREOF

ANTIBODY THAT BINDS TO VEGF-A AND IL6 AND METHODS OF USE

POLYPEPTIDES THAT BIND COMPLEMENT COMPONENT C5 OR SERUM ALBUMIN AND FUSION PROTEINS THEREOF

ANTI-TRANSTHYRETIN (TTR) BINDING PROTEINS AND USES THEREOF

HIGH AFFINITY ANTIBODIES SPECIFICALLY BINDING TO a-1,6-CORE-FUCOSYLATED ALPHA-FETOPROTEIN

MULTIVALENT LINKERS USED FOR ANTIBODY LABELING

Library of Antigen-Binding Molecules Including Modified Antibody Variable Region

ANTI-MIGIS-alpha ANTIBODIES AND METHODS OF USE THEREOF

ANTI-PCSK9 ANTIBODIES

MASP-2-TARGETTING ANTIBODIES AND USES THEREOF

METHODS OF TREATING BLOOD DISORDERS WITH VWF-TARGETED MONOSPECIFIC ANTIBODIES

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

ANTI-STEAP1 ANTIGEN-BINDING PROTEIN

OPTIMIZED ANTIBODIES TARGETING TROP2 AND USES THEREOF

ANTI-5T4 ANTIBODIES AND USES THEREOF

ANTI-CD3 AND ANTI-CD20 BISPECIFIC ANTIBODY AND USE THEREOF

ANTI-NGF ANTIBODIES AND METHODS OF TREATING PAIN THEREOF

IL3Ra Antibody Conjugates and Uses Thereof

ANTIBODY TARGETING CD25, AND PREPARATION METHOD THEREFOR AND USE THEREOF

ANTI-ALK1 ANTIBODIES AND METHODS OF USING THE SAME

Fc DOMAIN VARIANTS WITH ENHANCED Fc RECEPTOR BINDING

MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AND METHODS OF USE

FUSION PROTEIN, AND PREPARATION METHOD THEREFOR AND USE THEREOF

ANTIBODIES TO PROGRAMMED CELL DEATH PROTEIN 1

HUMAN ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF

CANCER TREATMENT TARGETING DLL3

ANTI-IL-27 ANTIBODIES AND USES THEREOF

ANTI-TNF-ALPHA ANTIBODIES AND COMPOSITIONS

ANTIGEN BINDING PROTEINS CAPABLE OF BINDING THYMIC STROMAL LYMPHOPOIETIN

ANTI-HUMAN CXCL1 ANTIBODY

METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING FIBROSIS

PREVENTION AND TREATMENT OF HEADACHES

ANTIBODY-BASED THERAPY OF TRANSTHYRETIN (TTR) AMYLOIDOSIS AND HUMAN-DERIVED ANTIBODIES THEREFOR

CYCLIC EPITOPE TAGS

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

Antibodies that Bind CD3 Epsilon

TUMOR-SPECIFIC BISPECIFIC IMMUNE CELL ENGAGER

TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF

ANTI-IMMUNOGLOBULIN DEGRADING ENZYME-DIGESTED FC VARIANT

POLYPEPTIDE ENGINEERING, LIBRARIES, AND ENGINEERED CD98 HEAVY CHAIN AND TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES

CD137 AGONIST ANTIBODIES AND USES THEREOF

CHIMERIC ANTIGEN RECEPTORS TARGETING CD70

Methods and Compositions Relating to Adenosine Receptors

ANTIGEN-BINDING PROTEIN AND USE THEREOF

HUMAN IGG1 FC REGION VARIANTS AND USES THEREOF

IMMUNOSUPPRESIVE AGENT

ANTI-PD-L1/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF

ANTI- PROGRAMMED DEATH-LIGAND 1 (PD-L1) ANTIBODY MOLECULES, ENCODING POLYNUCLEOTIDES, AND METHODS OF USE

CYTOKINE FUSION PROTEIN

ANTI-SIGLEC-7 ANTIBODIES AND METHODS OF USE THEREOF

ANTIBODIES TARGETING THE B-CELL RECEPTOR OF CHRONIC LYMPHOCYTIC LEUKEMIA AND USES THEREOF

GPRC5D ANTIBODY AND APPLICATION THEREOF

ANTI-IL-17A ANTIBODIES AND THEIR USE IN TREATING AUTOIMMUNE AND INFLAMMATORY DISORDERS

EGFL6 SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE

SUBCUTANEOUS DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

ANTIBODY-BASED THERAPY OF TRANSTHYRETIN (TTR) AMYLOIDOSIS AND HUMAN-DERIVED ANTIBODIES THEREFOR

ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS

ANTI-APOE ANTIBODIES

Humanized Anti-TDP-43 Binding Molecules and Uses Thereof

RECOMBINANT ANTIBODY OF ANTI-HUMAN CARDIAC TROPONIN I

HERV-K ANTIBODY, CELL, VACCINE, AND DRUG THERAPEUTICS

HUMAN MONOCLONAL ANTIBODIES TARGETING THE S2 SUBUNIT OF THE SARS-COV-2 SPIKE PROTEIN

Therapeutic Biologic For Treatment Of Glioblastoma

POLYPEPTIDES FOR COMPLEMENT INHIBITION

CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF

Anti-SIRP-Alpha Antibodies and Methods of Use Thereof

DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AND ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)

COMPOSITIONS, DEVICES, AND METHODS FOR TREATING CNS DISORDERS

ANTI-TMPRSS6 ANTIBODIES AND USES THEREOF

NOVEL MASKED ANTIBODIES

ANTI-HER2 ANTIBODIES AND METHODS OF USE THEREOF

SEMENOGELIN NEUTRALIZING ANTIBODY AND EPITOPE AND APPLICATION THEREOF

ANTI-CD73 ANTIBODIES AND USE THEREOF

Methods For Prevention Of Graft Rejection In Xenotransplantation

HUMAN LIFR ANTIGEN BINDING PROTEIN, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF